GLP-1 and surgery: do you have to stop before an operation?

If you take a GLP-1 and have an operation, a colonoscopy, or anything with sedation on the calendar, you’ve probably seen alarming takes online — “you must stop it a week before” or “they’ll cancel your surgery.” The real picture is more reassuring and more nuanced than either, and the official advice actually changed in 2024. This page walks through what’s established, what isn’t, what the current guidance says, and the one thing everyone should do. It’s education, not a substitute for your own care team’s instructions.

The one thing to do, no matter what

Before any procedure with anesthesia or sedation, tell your surgeon, anesthesia team, and (for scopes) your endoscopy team that you take a GLP-1 — and do it well in advance, not the morning of. The decision about whether to keep taking it or hold a dose is theirs to make with you, based on your medicine, your dose, your symptoms, and the procedure. Two rules follow from that: never stop the medicine on your own without asking, and never leave it off your medication list. (If you take it for type 2 diabetes, stopping also affects your blood-sugar control — one more reason it’s the team’s call, not yours.) Expect the final plan to be settled on the day, too: the team may adjust based on how you are that morning — your symptoms, whether you fasted well, and sometimes a quick bedside ultrasound.

Just as important, don’t swing the other way: being on a GLP-1 is not a reason to cancel or put off a needed operation — or a screening like a colonoscopy. It’s a reason to have the conversation. The team has several ways to do the procedure safely (below), and a delayed colonoscopy or postponed surgery carries its own real risks.

And if it’s an emergency? If you need urgent or emergency care, you may not be able to hold the drug or fast first — and that’s expected, so never delay emergency care over this. Anesthesia teams routinely treat any emergency or unfasted patient as if the stomach is full and take airway precautions as a matter of course. This is also why carrying your GLP-1 on a medication list — or telling someone close to you — matters: so it’s known even if you can’t say it yourself. Everything below is context for that conversation, not instructions to self-manage.

Why surgery teams care: the mechanism Established

GLP-1s work partly by slowing how fast the stomach empties. The practical consequence for anesthesia: even after the standard overnight fast, some people still have food or fluid left in the stomach. This part is well documented. In a 2024 study using bedside ultrasound, about 56% of fasted people on a GLP-1 had retained stomach contents, versus about 19% of people not taking one. Under anesthesia or deep sedation, the reflexes that normally protect your airway are blunted, so anything left in the stomach could, in principle, come up and get into the lungs (aspiration). That’s the worry driving all of this.

But does the retained food actually cause harm? Observational — currently unproven

Here’s the honest gap that most viral advice skips. “More food in the stomach” and “more people actually harmed” are two different claims, and only the first is well supported. When large 2025 analyses pooled real-world data on actual aspiration events, they did not find a significant increase among GLP-1 users — the rates came out roughly the same as non-users. But read that carefully: aspiration is a rare event and this pooled data is observational and graded low-certainty, so these studies may simply be too underpowered to detect a small difference. The honest reading is “no increased harm has been shown yet,” not “there is no risk.” The mechanism is real and worth respecting; what hasn’t been shown is that it’s translating into dangerous aspirations in the OR. That balance — real mechanism, unproven harm — is exactly why the guidance loosened rather than tightened.

What the current guidance actually says Expert consensus

The advice has two versions, and the newer one matters:

• 2023 (the version still circulating online): the 2023 ASA guidance advised holding the medicine before every procedure — daily doses on the day of, weekly injections about a week ahead. This was based largely on case reports, before the outcome data existed.
• October 2024 (the current multi-society guidance): this updated the approach and, in practice, superseded the blanket hold. Its thrust is that most patients can continue their GLP-1, with the team individualizing based on risk factors (being early in dose increases, on a high or weekly dose, or having ongoing nausea, vomiting, or reflux). When there’s concern, options include a longer clear-liquid diet before the procedure, a day-of stomach ultrasound, and — importantly — treating the stomach as potentially full and taking extra airway precautions during anesthesia rather than automatically cancelling. The societies are candid that this is guidance, not a hard evidence-based rule, and that the data behind any specific “hold for X days” schedule is weak.

The takeaway for you isn’t a schedule to follow — it’s that a good anesthesia team has several tools here, and stopping your medicine is only one of them, chosen (or not) for your situation.

Where it applies, and where the risk tilts higher

This isn’t only about major surgery. It applies to general anesthesia, deep or procedural sedation, and endoscopy or colonoscopy under sedation. The considerations weigh more heavily if you are early in dose escalation, on a higher or weekly-injection dose, or still having GI symptoms like nausea, vomiting, or reflux — all signs the stomach may be emptying more slowly. They weigh less for someone long-stable on a low dose with no symptoms. Your team sorts this out; your job is to give them the information early.

What to bring to the conversation

A few things make that pre-procedure conversation more useful — our visit-agenda builder can assemble them:

• Which GLP-1 you take, the dose, and when your last dose was (or will be).
• Whether you’ve had recent nausea, vomiting, reflux, or a sense of food “sitting.”
• Any recent dose increase.

For the broader picture of how these drugs affect digestion, see GLP-1 side effects and the lesser-known effects. As always, your surgical and anesthesia team’s specific instructions come first — this page is to help you have that conversation, not to replace it.